Category Matches
- 5-a-reductase Inhibitors
- 5-HT1 Receptors - Analgesics
- 5-HT1 Receptors - Antidepressant
- 5-HT1 Receptors - Antipsychotic
- 5-HT1 Receptors - Anxiolytic
- 5-HT1 Receptors - Cognition Enhancing
- 5-HT1 Receptors - Hypnotics
- 5-HT1 Receptors - Sedatives
- 5-HT2 Receptors - Analgesics
- 5-HT2 Receptors - Antidepressant
- 5-HT2 Receptors - Antipsychotic
- 5-HT2 Receptors - Anxiolytic
- 5-HT2 Receptors - Cognition Enhancing
- 5-HT2 Receptors - Hypnotics
- 5-HT2 Receptors - Neurodegenerative Diseases
- 5-HT2 Receptors - Sedatives
- 5-HT3 Receptors - Analgesics
- 5-HT3 Receptors - Antidepressant
- 5-HT3 Receptors - Antipsychotic
- 5-HT3 Receptors - Anxiolytic
- 5-HT3 Receptors - Cognition Enhancing
- 5-HT3 Receptors - Hypnotics
- 5-HT3 Receptors - Sedatives
- 5-HT5 Receptors - Analgesics
- 5-HT5 Receptors - Antidepressant
- 5-HT5 Receptors - Antipsychotic
- 5-HT5 Receptors - Anxiolytic
- 5-HT5 Receptors - Cognition Enhancing
- 5-HT5 Receptors - Neurodegenerative Diseases
- 5-HT5 Receptors - Sedatives
- 5-HT6 Receptors - Analgesics
- 5-HT6 Receptors - Antidepressant
- 5-HT6 Receptors - Antipsychotic
- 5-HT6 Receptors - Anxiolytic
- 5-HT6 Receptors - Cognition Enhancing
- 5-HT6 Receptors - Neurodegenerative Diseases
- 5-HT6 Receptors - Sedatives
- 5-HT7 Receptors - Analgesics
- 5-HT7 Receptors - Antidepressant
- 5-HT7 Receptors - Antipsychotic
- 5-HT7 Receptors - Anxiolytic
- 5-HT7 Receptors - Cognition Enhancing
- 5-HT7 Receptors - Sedatives
- 5-Lipoxygenase Inhibitors
- 5-α-Reductase Inhibitors
- 6-hydroxydopamine
- a-Glucosidase Inhibitors
- Acetyl-CoA Carboxylase Inhibitor
- AChE - Neurodegenerative Diseases
- ACTH Agonists
- Activin-like Kinase
- Adenosine Antagonists (Xanthines)
- Adenosine Receptors - Analgesics
- Adenosine Receptors - Antiepileptics and Anticonvulsants
- Adenosine Receptors - Anxiolytic
- Adenosine Receptors - Cognition Enhancing
- Adenosine Receptors - Neurodegenerative Diseases
- Adenosine Receptors - Sedatives
- Adrenergic Agonists
- Adrenergic Receptors - Analgesics
- Adrenergic Receptors - Anesthetic
- Adrenergic Receptors - Antidepressant
- Adrenergic Receptors - Antiepileptics and Anticonvulsants
- Adrenergic Receptors - Antipsychotic
- Adrenergic Receptors - Anxiolytic
- Adrenergic Receptors - Cognition Enhancing
- Adrenergic Receptors - Hypnotics
- Adrenergic Receptors - Neurodegenerative Diseases
- Adrenergic Receptors - Sedatives
- Aldosterone and ENaC Antagonists (K+ Sparing diuretics)
- Aldosterone Antagonists
- Aldosterone Antagonists - Antihypertensive
- Alzheimer's Disease
- Alzheimer's Disease
- AMPA - Neurodegenerative Diseases
- AMPK - Neurodegenerative Diseases
- Amylin Agonists
- anabasine
- anastrozole
- Androgen Receptor Modulators
- Anti-asthma
- Anti-metastatic
- Anti-parasitic
- Anti-parasitic
- Antihistamines - Therapies for Respiratory Diseases and Allergy Management
- Aromatase Inhibitors - Anticancer
- Aromatase Inhibitors - Immunology
- ASK
- BChE - Neurodegenerative Diseases
- Beta-Adrenergic Agonists
- Beta-Adrenergic Receptor Antagonists
- Blog Post
- Bone Disease Treatments
- Ca2+ Channel Blockers - Vasodilatory
- Ca2+ Ion Channels - Neurodegenerative Diseases
- Ca2+-sensing Receptors - Neurodegenerative Diseases
- Calcitriol (VDR) Agonists
- Cannabinoid Receptors - Analgesics
- Cannabinoid Receptors - Antidepressant
- Cannabinoid Receptors - Anxiolytic
- Cannabinoid Receptors - Sedatives
- Cardiovascular
- CCK Receptor Antagonists
- CCK Release Inhibitors
- CCK Release Stimulators
- Class I (Na+ Channel Blocker)
- Class II (Beta Blocker)
- Class III (K+ Channel Blocker)
- Class IV (Ca2+ Channel Blocker)
- Class V (Other)
- COMT - Neurodegenerative Diseases
- Corticotropin Releasing Factor
- D-amino Acid Oxidase - Analgesics
- D-amino Acid Oxidase - Antidepressant
- D-amino Acid Oxidase - Antipsychotic
- D-amino Acid Oxidase - Sedatives
- D1 Receptors - Analgesics
- D1 Receptors - Anesthetic
- D1 Receptors - Antidepressant
- D1 Receptors - Antipsychotic
- D1 Receptors - Anxiolytic
- D1 Receptors - Cognition Enhancing
- D1 Receptors - Neurodegenerative Diseases
- D1 Receptors - Sedatives
- D2 Receptor Antagonists
- D2 Receptors - Analgesics
- D2 Receptors - Anesthetic
- D2 Receptors - Antidepressant
- D2 Receptors - Antipsychotic
- D2 Receptors - Anxiolytic
- D2 Receptors - Cognition Enhancing
- D2 Receptors - Neurodegenerative Diseases
- D2 Receptors - Sedatives
- D3 Receptors - Analgesics
- D3 Receptors - Antidepressant
- D3 Receptors - Antipsychotic
- D3 Receptors - Anxiolytic
- D3 Receptors - Cognition Enhancing
- D3 Receptors - Neurodegenerative Diseases
- D3 Receptors - Sedatives
- D4 Receptors - Analgesics
- D4 Receptors - Antidepressant
- D4 Receptors - Antipsychotic
- D4 Receptors - Anxiolytic
- D4 Receptors - Cognition Enhancing
- D4 Receptors - Neurodegenerative Diseases
- D4 Receptors - Sedatives
- D5 Receptors - Antidepressant
- D5 Receptors - Antipsychotic
- D5 Receptors - Anxiolytic
- D5 Receptors - Cognition Enhancing
- D5 Receptors - Sedatives
- DA Receptor Signaling - Analgesics
- DA Receptor Signaling - Anesthetic
- DA Receptor Signaling - Antidepressant
- DA Receptor Signaling - Antipsychotic
- DA Receptor Signaling - Anxiolytic
- DA Receptor Signaling - Cognition Enhancing
- DA Receptor Signaling - Neurodegenerative Diseases
- DA Receptor Signaling - Sedatives
- daclatasvir
- DAT - Neurodegenerative Diseases
- dexamethasone
- dexamethasone
- diallyl tetrasulfide
- diclofenac
- Dihydrofolate Reductase
- Dihydrofolate Reductase Inhibitors
- DNA Methyltransferase
- DNA Polymerase
- dopamine agonists
- Dopamine Receptor Inhibitors
- dopaminergic neurons
- DOT1L Histone Methyltransferase
- ebastine
- eIF2B - Neurodegenerative Diseases
- elbasvir
- Endothelin Receptor Antagonists
- Epinephrine/NE Agonists
- Estrogen Receptor Inhibitors
- EZH2 Histone Methyltransferase
- Fast Skeletal Muscle Troponin Complex - Neurodegenerative Diseases
- fexofenadine
- Furans - Anti-parasitic
- GABA - Neurodegenerative Diseases
- Gamma Secretase - Neurodegenerative Diseases
- Gastric Inhibitory Peptide
- Gastrin Agonists
- Gastrin-releasing Peptide
- Gastrointestinal Motility Modulators
- Ghrelin Agonists
- GHRH Agonists
- GLP-1 Agonists
- Glucagon Agonists
- GnRH Agonists
- Gut/Gastrointestinal Hormones
- Histamine Receptors - Analgesics
- Histamine Receptors - Antidepressant
- Histamine Receptors - Antipsychotic
- Histamine Receptors - Anxiolytic
- Histamine Receptors - Cognition Enhancing
- Histamine Receptors - Hypnotics
- Histamine Receptors - Neurodegenerative Diseases
- Histamine Receptors - Sedatives
- Histone Deacetylase
- HMG-CoA Reductase Inhibitors (Statins)
- Hormone Receptor Modulators
- Imidazoline Receptors - Analgesics
- Imidazoline Receptors - Antipsychotic
- Imidazoline Receptors - Cognition Enhancing
- Imidazoline Receptors - Neurodegenerative Diseases
- Imidazoline Receptors - Sedatives
- Indoleamine 2,3-dioxygenase
- Inhibitors of other enzymes
- Integrase Inhibitors
- Ion Channels - Neurodegenerative Diseases
- K+ Ion Channels - Neurodegenerative Diseases
- kashin-beck
- Kynurenine 3-hydroxylase - Neurodegenerative Diseases
- ledipasvir
- Leptin Agonists
- Leukotriene Receptor Antagonists
- Lipotropin Agonists
- Lipoxygenase - Analgesics
- Lovastatin
- LRRK2 - Neurodegenerative Diseases
- mAChR - Neurodegenerative Diseases
- Macrolides - Anti-parasitic
- Madagascar periwinkle
- MAO - Neurodegenerative Diseases
- masitinib
- Mast Cell Stabilizers
- MCH Agonists
- Melatonin Receptors - Analgesics
- Melatonin Receptors - Antidepressant
- Melatonin Receptors - Anxiolytic
- Melatonin Receptors - Hypnotics
- Melatonin Receptors - Neurodegenerative Diseases
- Melatonin Receptors - Sedatives
- Motilin Agonists
- MSH Agonists
- Muscarininc Acetylcholine Receptor Inhibitors
- Na+ Ion Channels - Neurodegenerative Diseases
- nAChR - Neurodegenerative Diseases
- NET - Neurodegenerative Diseases
- Neuraminidase Inhibitors
- Neurodegenerative Diseases
- neuroinflammation
- Nitroimidazoles - Anti-parasitic
- Nitrosoureas
- Nitrovasodilators
- NK - Neurodegenerative Diseases
- NMDA Receptors - Neurodegenerative Diseases
- odontoblast
- Opioid Peptide Agonists
- Opioid Receptor Agonists
- Opioid Receptor Antagonists
- Opioid Receptors - Analgesics
- Opioid Receptors - Anesthetic
- Opioid Receptors - Antidepressant
- Opioid Receptors - Antiepileptics and Anticonvulsants
- Opioid Receptors - Anxiolytic
- Opioid Receptors - Cognition Enhancing
- Opioid Receptors - Neurodegenerative Diseases
- Opioid Receptors - Sedatives
- Orexin Receptors - Sedatives
- Organosulfurs - Anti-parasitic
- Other DA Signaling - Neurodegenerative Diseases
- outofstock
- oxidopamine
- Parathyroid Hormone Agonists
- Parkinson's Disease
- Platinum-based Agents
- PPAR Agonists
- PPAR Agonists (Fibrates)
- PPAR-a Agonists
- PPAR-y Agonists
- prexasertib
- Profens
- Prolactin-releasing Peptide Agonists
- Prolyl Oligopeptidase - Neurodegenerative Diseases
- propofol
- Prostaglandin D Synthase Inhibitors
- Prostaglandin Synthetase - Analgesics
- Protease Inhibitors
- proteasome
- Protein Arginine Methyltransferase
- Ras
- Reverse Transcriptase Inhibitors
- Ribonucleotide Reductase
- RNA Polymerase
- rosuvastatin
- Secretin Agonists
- Serine/Threonine Kinase Inhibitors
- Serotonin (5-HT3) Receptor Inhibitors
- Serotonin Receptors - Analgesics
- Serotonin Receptors - Antidepressant
- Serotonin Receptors - Antipsychotic
- Serotonin Receptors - Anxiolytic
- Serotonin Receptors - Cognition Enhancing
- Serotonin Receptors - Hypnotics
- Serotonin Receptors - Neurodegenerative Diseases
- Serotonin Receptors - Sedatives
- SERT - Neurodegenerative Diseases
- Sigma Receptors - Antidepressant
- Sigma Receptors - Antiepileptics and Anticonvulsants
- Sigma Receptors - Antipsychotic
- Sigma Receptors - Anxiolytic
- Sigma Receptors - Cognition Enhancing
- Sigma Receptors - Neurodegenerative Diseases
- Sigma Receptors - Sedatives
- SIRT - Neurodegenerative Diseases
- sofosbuvir
- sofosbuvir
- Somatostatin Agonists
- Soy Isoflavones
- Sulfonylureas
- taselisib
- Telomerase
- Tetracyclines - Anti-parasitic
- Therapies for Respiratory Diseases and Allergy Management
- Thioredoxin Reductase
- Thromboxane Receptor Antagonists
- Thymidylate Synthase
- Thymopoietin/Thymopentin Agonists
- Thymosin Agonists
- Thymulin Agonists
- Thyroid Hormone Agonists
- Topoisomerase
- Topoisomerase Inhibitors
- tranilast
- TRH Agonists
- Triple-negative breast cancer
- Trk Receptors - Cognition Enhancing
- Trk Receptors - Neurodegenerative Diseases
- TRP Channels - Neurodegenerative Diseases
- Tyrosine Kinase Inhibitors
- Vasodilatory
- Vasopressin Agonists
- velpatasvir
- vinblastine
- VIP Agonists
- Vitamin K Antagonists
- α1-adrenergic Receptor Antagonists - Antihypertensive
- α1-adrenergic Receptor Antagonists - Vasodilatory
- α2-adrenergic Receptor Agonists
- β-Glucan Synthase Inhibitors (echinocandins)
- β-lactamase inhibitors
Product Matches
- New Product Spotlight: Endocannabinoid ModulatorsThe endocannabinoid system is a set of proteins and endogenous ligands that regu...
- A0916Acepromazine Maleate
Phenothiazine derivative; D1/2 and 5-HT1A/2A antagonist.
≥99% - D5662Dopamine Hydrochloride
Endogenous hormone neurotransmitter, involved in motor control, mood, cogniti...
≥99% - M1779Methyldopa Sesquihydrate
DOPA decarboxylase inhibitor, indirect α2-adrenergic agonist.
≥98% - G1975Gestrinone
Synthetic steroid hormone; AR agonist, ER and PR antagonist.
≥98% - D5649Domperidone
D2/3 antagonist, hERG K+ channel blocker.
≥98% - L589921Loxapine Succinate
D2 and D4 dopamine receptor inhibitor.
≥99% - B1898Bezafibrate
Fibrate; PPARα agonist.
≥98% - Q8019Quetiapine Fumarate
5-HT1A and σ1/2 agonist, 5-HT2A/2C/6/7, D1-4, histamine H1/2, M1 mAChR, α1A...
≥99% - G3457Ginsenoside Re
Triterpene saponin found in species of Panax; PPARγ agonist.
≥98% - C0267Carnosol
Diterpene compound originally found in Rosmarinus; PGE2 synthase inhibitor.
≥98%P6954Pioglitazone HydrochlorideThiazolidinedione; PPARα/γ agonist, mitoNEET modulator.
≥98%C4558Clonidine HydrochlorideImidazoline and α2-adrenergic agonist, Nav1.7 Na+ channel blocker.
≥98%B3210R-BicalutamideAR antagonist.
≥98%T5769Toremifene BaseSERM, androgen modulator.
≥98%C3250CimetidineHistamine H2 and AR antagonist, catalase inhibitor.
≥99%B3209BicalutamideAR antagonist.
≥98%A7034AripiprazoleD2 and 5-HT1A partial agonist, 5-HT2C/6/7 antagonist, SERT inhibitor.
≥98%L8261LupeolTriterpene; potential tyrosinase inhibitor.
≥98%A9713AZD-3514Androgen receptor downregulator.
≥98%